Home Health What is Avandia and why are Glaxosmithkline facing legal claims for its...

What is Avandia and why are Glaxosmithkline facing legal claims for its damaging effects?

0

Express Solicitors have begun legal proceedings against British pharmaceutical firm GlaxoSmithKline after a number of individuals have been seriously affected by the drug Avandia.

The diabetes drug Avandia was first introduced on to the NHS in the year 2000 and was used primarily to treat people with type 2 diabetes whose glucose levels were not being kept properly under control by the everyday, already in use drugs – a sulphonylurea drug and metformin. Avandia was created to lessen the body’s resistance towards insulin and could be used alone or together with metformin, which is also known as Avandamet.

The drug was banned in 2010 after ten years, due to very serious health concerns surrounding it. The health concerns connected with the drug were issues such as heart failure and heart attacks after a US scientist carried out clinical trials on 28,000 different people.

Avandia tablets, NLM Pillbox

Avandia tablets

GSK (a company who produces and sells a large range of prescription and over the counter medicines) faces legal action due to a number of instances where the drug Avandia was prescribed to patients eight weeks subsequent to the European medicines regulator ordering it to be removed. The pharmaceutical firm also admitted to covering up any data which showed the drugs damaging side effects.
The National Health Service is too facing difficulties of the same sort for the marketing and sale of the drug even after its ban in Europe.

Since the discovery of Avandia’s side effects, thousands of families have come forward demanding compensation for the death or harm of a close relative but only the US claimants have prevailed. GSK have agreed since to pay out billions of dollars to the US government to cover and settle any claims from people in the US.

However, despite the pharmaceutical company being of British origin, UK families may not be quite as well off, as GSK are not prepared to pay out without a fight to defend themselves. Whilst claimants in the US got it relatively easy, fighters in the UK will be faced with having to produce evidence such as medical expert opinions and reports to stand up in court.

Express Solicitors in Manchester are at present representing four families, with a further 15 on its books and are offering a “no win, no fee” basis for anyone affected by the drug.